stockrow
Friday 6 November 2026
Export SMMT’s income statement to Excel — free account
Summit Therapeutics PLC
SMMT Healthcare Biotechnology
Summit Therapeutics PLC’s revenue for fiscal 2022 (year ended December 2022) was $705,000.00.
- EPS
- +63.2%
- Free cash flow
- −112.8%
Quarter to June 2026, against a year earlier
15.75
1.56
+10.99%
Follow SMMT
Alert me
Summit Therapeutics PLC (SMMT) Gross margin
Summit Therapeutics PLC's gross margin over the twelve months to 31 December 2022 was 100.0%. Over the past ten years it has ranged from 0.00% (fiscal 2018) to 100.0% (fiscal 2022) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 65.2% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2022 | 100.0% | 0.00 |
| FY2021 | 100.0% | 0.00 |
| FY2020 | 100.0% | 0.00 |
| FY2019 | 100.0% | 0.00 |
| FY2019 | 100.0% | 100.00 |
| FY2018 | 0.00% | (100.00) |
| FY2018 | 100.0% | 100.00 |
| FY2017 | 0.00% | (100.00) |
| FY2017 | 100.0% | 100.00 |
| FY2016 | 0.00% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Dec 2022 | 0.00% | (100.00) |
| Sep 2022 | 100.0% | 0.00 |
| Jun 2022 | 100.0% | 0.00 |
| Mar 2022 | 100.0% | 0.00 |
| 23 more quarters | Free account |
Against its own ten years
Low 0.00%
High 100.0%
Ten-year median
100.0%
Current reading's percentile
100
Gross margin against peers
| Company | Gross margin |
|---|---|
| SMMT Summit Therapeutics PLC | 100.0% |
| KYMR Kymera Therapeutics, Inc. compare | 100.0% |
| BBIO BridgeBio Pharma, Inc. compare | 94.3% |
| ASND Ascendis Pharma A/S compare | 91.3% |
| JAZZ Jazz Pharmaceuticals PLC compare | 89.1% |
| HALO Halozyme Therapeutics, Inc. compare | 82.3% |
| BMRN BioMarin Pharmaceutical Inc. compare | 76.0% |
| TECH Bio-Techne Corp compare | 65.8% |
| PCVX Vaxcyte, Inc. compare | 0.00% |
| Biotechnology industry median | 65.2% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on SMMT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement